|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||
| Cash | ||||||||||
| Prepaid expenses | ||||||||||
| Total current assets | ||||||||||
| Deferred offering costs | ||||||||||
| Cash and investments held in Trust Account | ||||||||||
| Cash and investments held in trust account | ||||||||||
| Total assets | ||||||||||
| Current liabilities | ||||||||||
| Accrued deferred offering cost | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Due to related parties | ||||||||||
| Promissory note - related party | ||||||||||
| Working capital loans, related party | ||||||||||
| Total current liabilities | ||||||||||
| Deferred underwriting commission payable | ||||||||||
| Total liabilities | ||||||||||
| Class A ordinary shares subject to possible redemption, 8,500,000 shares at redemption value of $11.01 and $10.52 per share as of September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Class A Ordinary Shares | ||||||||||
| Total class A ordinary shares subject to possible redemption, 8,500,000 shares at redemption value of $11.01 and $10.52 per share as of September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Shareholders’ deficit | ||||||||||
| Ordinary shares value | ||||||||||
| Class A Ordinary Shares | ||||||||||
| Class B Ordinary Shares | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total shareholders’ deficit | ||||||||||
| Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ deficit |
Loading...